| 137 |
Dong-A ST Completes Marketing Authorization Application for Stelara Biosimilar DMB-3115 at EMA |
2023-07-14 |
| 136 |
Dong-A ST Donates Disinfectant Wipes to Dongdaemun-gu Community Center |
2023-06-21 |
| 135 |
Dong-A ST Signs MOU with KT for Medical Education Collaboration in Vietnam |
2023-06-14 |
| 134 |
Dong-A ST Earns Fourth Consecutive Consumer-Centered Management (CCM) Certification |
2023-06-09 |
| 133 |
Dong-A ST Recruiting Participants for Youth Environmental and Life Love Classroom |
2023-05-23 |
| 132 |
Dong-A ST Launches Combination Diabetes Treatment, Sugadapa Tab |
2023-05-04 |
| 131 |
Dong-A ST Receives FDA Approval for Phase 2 Clinical Trial of NeuroBo’s NASH Drug DA-1241 |
2023-05-03 |
| 130 |
Dong-A ST Confirms High Efficacy in Phase 4 Clinical Trial of Jublia for Koreans |
2023-04-26 |
| 129 |
Dong-A ST Publishes Study on Suganon's Preventive Effect on Diabetic Cardiomyopathy |
2023-04-25 |
| 128 |
Dong-A ST Presents Preclinical Results for Immuno-Oncology Drug DA-4505 at AACR 2023 |
2023-04-20 |
